Johnson & Johnson has outpaced the S&P 500 over the past year, and analysts remain optimistic about the healthcare stock's growth potential ahead.
Palo Alto Networks has underperformed the Dow over the past year, yet analysts remain moderately optimistic about the stock’s prospects.
Regeneron Pharmaceuticals has underperformed the S&P 500 over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Medtronic has outperformed the Medical Devices industry over the past year, and analysts are cautiously optimistic about the stock’s prospects.
Lockheed Martin stock has lagged behind the S&P 500 Index over the past year, but analysts are cautiously optimistic about the stock's prospects.
Broadcom (AVGO) is due to report earnings after the market close on December 11th and the market is pricing in a 10.1% move in either direction.
Boston Scientific has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.
TJX Companies has outperformed the Dow Jones index over the past year. Moreover, Wall Street analysts remain strongly optimistic about its prospects.
Vertex Pharmaceuticals has underperformed the broader Nasdaq index over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.
While Duke Energy has lagged behind its sector peers, Wall Street remains optimistic about the stock.
